Page last updated: 2024-09-02

oxymatrine and Fatty Liver

oxymatrine has been researched along with Fatty Liver in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hu, Z; Shi, L; Song, G; Wang, C; Zhang, D; Zhang, H1
Hu, ZJ; Shi, L; Shi, LJ; Song, GY; Wang, C; Zhang, DH; Zhang, HF1
Chan, SM; Molero, JC; Xu, J; Xue, CL; Ye, JM; Zeng, XY; Zhou, X1

Other Studies

3 other study(ies) available for oxymatrine and Fatty Liver

ArticleYear
Oxymatrine ameliorates non-alcoholic fatty liver disease in rats through peroxisome proliferator-activated receptor-α activation.
    Molecular medicine reports, 2013, Volume: 8, Issue:2

    Topics: Alkaloids; Animals; Body Weight; Disease Models, Animal; Fatty Liver; Insulin Resistance; Intra-Abdominal Fat; Lipid Metabolism; Lipids; Liver; Male; Non-alcoholic Fatty Liver Disease; Organ Size; PPAR alpha; Quinolizines; Rats

2013
Oxymatrine attenuates hepatic steatosis in non-alcoholic fatty liver disease rats fed with high fructose diet through inhibition of sterol regulatory element binding transcription factor 1 (Srebf1) and activation of peroxisome proliferator activated recep
    European journal of pharmacology, 2013, Aug-15, Volume: 714, Issue:1-3

    Topics: Alkaloids; Animals; Body Weight; Diet; Dose-Response Relationship, Drug; Dyslipidemias; Energy Intake; Fatty Acids; Fatty Liver; Fructose; Gene Expression Regulation; Liver; Male; Non-alcoholic Fatty Liver Disease; Oxidation-Reduction; PPAR alpha; Quinolizines; Rats; Rats, Wistar; RNA, Messenger; Signal Transduction; Sterol Regulatory Element Binding Protein 1

2013
Screening for the efficacy on lipid accumulation in 3T3-L1 cells is an effective tool for the identification of new anti-diabetic compounds.
    Biochemical pharmacology, 2012, Sep-15, Volume: 84, Issue:6

    Topics: 3T3-L1 Cells; Adiposity; Alkaloids; Animals; Anti-Obesity Agents; Bridged-Ring Compounds; Cell Line; Dietary Fats; Drug Evaluation, Preclinical; Drugs, Chinese Herbal; Fatty Liver; Fructose; Glucose Intolerance; High-Throughput Screening Assays; Hypoglycemic Agents; Insulin Resistance; Lipid Metabolism; Male; Mice; Mice, Inbred C57BL; Quinolizines; Triglycerides

2012